QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30 - 收藏  |  浏览/下载：10/0  |  提交时间：2020/10/26 PHASE-I  POSTMENOPAUSAL WOMEN  HDAC INHIBITOR  MULTICENTER  ENTINOSTAT  TAMOXIFEN  CS055/HBI-8000  RESISTANCE  LETROZOLE  TRIAL  Advanced breast cancer  hormone receptor-positive  chidamide  exemestane   Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy 期刊论文 ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 卷号: 17, 期号: 6, 页码: 802-812 作者:  Gao, Shuai;  Li, Xiaoyang;  Zang, Jie;  Xu, Wenfang;  Zhang, Yingjie 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/12 Epigenetic  histone deacetylase inhibitors  chidamide  hematologic and  solid cancers  preclinical and clinical trials   CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G(1) arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells 期刊论文 BIOCHEMICAL JOURNAL, 2012, 卷号: 443 作者:  Gong, Ke;  Xie, Jia;  Yi, Hong;  Li, Wenhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 apoptosis  CS055  differentiation  histone deacetylase inhibitor (HDACi)  leukaemia  proliferation inhibition  reactive oxygen species (ROS)   Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity 期刊论文 2012, 卷号: 69, 期号: 4, 页码: 901-909 作者:  Ning, Zhi-Qiang 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Chidamide  HDAC inhibitor  Antitumor activity  Immune cell-mediated cytotoxicity   Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas 期刊论文 2012, 卷号: 69, 期号: 6, 页码: 1413-1422 作者:  Dong, Mei;  Ning, Zhi-Qiang;  Xing, Pu-Yuan;  Xu, Jia-Lian;  Cao, Hai-Xiang 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Chidamide  HDAC inhibitor  Phase I  Solid tumor  Lymphoma